Related Experiment Videos
Tonsillar microbial flora: comparison of recurrent tonsillitis and normal tonsils
A Stjernquist-Desatnik1, E Holst
1Department of Otorhinolaryngology, University Hospital, Lund, Sweden.
Acta Oto-Laryngologica
|April 29, 1999
Summary
Recurrent tonsillitis is not linked to beta-lactamase bacteria or reduced viridans streptococci in tonsils. This study found no support for these common theories regarding recurrent group A streptococcal infections.
Area of Science:
- Microbiology
- Otolaryngology
Background:
- Recurrent group A streptococcal pharyngotonsillitis is a common condition.
- The role of tonsillar microbial flora in recurrent infections is not fully understood.
- Hypotheses include bacterial inactivation of antibiotics or loss of beneficial bacteria.
Purpose of the Study:
- To investigate the tonsillar microbial flora in patients with recurrent group A streptococcal tonsillitis compared to controls.
- To test the hypothesis that beta-lactamase-producing bacteria or reduced viridans streptococci contribute to recurrent tonsillitis.
Main Methods:
- Tonsillar core specimens were cultured from 34 patients undergoing tonsillectomy.
- Patients were divided into recurrent tonsillitis (n=17) and sleep apnea (control, n=17) groups.
- Semi-quantitative cultures assessed aerobic, anaerobic, and facultative organisms, including beta-lactamase producers and viridans streptococci.
Main Results:
- No significant differences were found in the mean number of aerobic or anaerobic isolates between the groups.
- The proportion of beta-lactamase producers and the frequency of viridans streptococci were similar in both recurrent tonsillitis and control groups.
- No significant differences in bacterial growth intensity were observed between the patient groups.
Conclusions:
- The study found no evidence to support the hypothesis that beta-lactamase-producing bacteria or altered viridans streptococci levels cause recurrent group A streptococcal tonsillitis.
- Alternative explanations, such as poor antibiotic penetration, warrant further investigation for recurrent tonsillitis treatment.